| Literature DB >> 21241980 |
Itsik Ben-Dor1, Gabriel Maluenda, Augusto D Pichard, Lowell F Satler, Robert Gallino, Joseph Lindsay, Ron Waksman.
Abstract
Excimer laser coronary atherectomy (ELCA) has been used for coronary intervention for more than 20 years. Advances in delivery systems for laser energy using the xenon-chlorine pulsed laser catheter deliver higher energy density with lower heat production. The Spectranetics CVX-300 (Spectranetics, Colorado Springs, CO, USA) excimer laser catheter system has been used for the treatment of complex coronary lesions. We report our experience with the use of this advanced system for stenoses for which were unsuitable for standard percutaneous coronary intervention; for example, balloon-resistant lesions, chronic total occlusions, and for underexpanded stents in calcified lesions. ELCA may also be valuable for thrombus-containing lesion. We find ELCA to be indispensable in the catheterization laboratory for specific complex or calcified lesions. Its role should be explored in a large randomized trial of thrombus containing lesions and saphenous vein grafts.Entities:
Mesh:
Year: 2010 PMID: 21241980 DOI: 10.1016/j.carrev.2010.06.008
Source DB: PubMed Journal: Cardiovasc Revasc Med ISSN: 1878-0938